Pfizer chasing AstraZeneca for potential $100 billion deal-Reuters

U.S. drugmaker Pfizer Inc is working on its next move in a potential $100 billion battle for Britain's AstraZeneca Plc after having two bids rejected, as deal-making grips the healthcare industry, Reuters reported.

DealsNorth AmericaUSBriefs